Entera Health, Inc. To Announce New Intended Use Statement At ACG 2016

The Company has redefined foundational information for its medical food product EnteraGam® (serum-derived bovine immunoglobulin/protein isolate, SBI) 

Entera Health, Inc. today announced that it has revised its statement of intended use for EnteraGam® to now read, “EnteraGam® is a medical food product intended for the dietary management of chronic diarrhea and loose stools.  EnteraGam® must be administered under medical supervision.”

The company has timed the revision to coincide with the 2016 American College of Gastroenterology’s (ACG) Annual Scientific Meeting & Postgraduate Course, where Entera Health will have a booth at the Venetian in Las Vegas, NV, from Friday, October 14 to Wednesday, October 19.

To learn more about the significance of this change, visit the Entera Health booth #551 at ACG 2016 or explore the product website at enteragam.com.

About EnteraGam® / Intended Use:

EnteraGam® is a medical food product intended for the dietary management of chronic diarrhea and loose stools.  EnteraGam® must be administered under medical supervision.

Important Safety Information:

EnteraGam® contains beef protein: therefore, patients who have an allergy to beef or any other component of EnteraGam® should not take this product.  EnteraGam® has not been studied in pregnant women, in women during labor and delivery, or in nursing mothers.  The choice to administer EnteraGam® during pregnancy, labor and delivery, or to nursing mothers is at the clinical discretion of the prescribing physician.

EnteraGam® does not contain any milk-derived ingredients such as lactose, casein, or whey.  EnteraGam® is gluten-free, dye-free, and soy-free. 

Please see full Product Information.

To report suspected adverse reactions, contact Entera Health, Inc. at 1-855-4ENTERA (1-855-436-8372), or the FDA at 1-800-FDA-1088 (1-800-332-1088) or www.fda.gov/medwatch.

For information, please contact:
Aage Lauridsen, Chief Executive Officer


View Press Release Online